English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 31 May 2017, 11:05 HKT/SGT
Share:
Shandong Luoxin Pharmaceutical's Withdrawal of Listing H Shares on HKEx Approved by Shareholders; Offer becomes Unconditional in All Respects
- The Liquidity of the H Shares May be Severely Reduced after Delisting on 16 June 2017
- The Latest Time and Date for the Offer Remaining Open for Acceptance is 4:00 p.m. on 26 June 2017

HONG KONG, May 31, 2017 - (ACN Newswire) - Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. ("Shandong Luoxin Pharmaceutical" or the "Company") (stock code: 8058) has announced that the resolution for the proposed withdrawal of listing of the H shares of the Company ("H Shares") from The Stock Exchange of Hong Kong Limited (the "Stock Exchange") was passed by way of poll at the extraordinary general meeting and the H Share class meeting of the Company held on 29 May 2017. The voluntary conditional offer ("Offer") by Giant Star Global (HK) Limited and Ally Bridge Flagship LX (HK) Limited (together, the "Joint Offerors") for all the issued H Shares (other than those already owned, controlled or agreed to be acquired by the Joint Offerors and parties acting in concert with any of them who have undertaken not to accept the Offer) became unconditional in all respects on 29 May 2017.

The last day of dealing in the H Shares on the Stock Exchange will be 5 June 2017. Trading in the H Shares will be suspended from 6 June 2017 and will remain suspended until the withdrawal of listing of the H Shares from the Stock Exchange from 9:00 a.m. on 16 June 2017.

The Joint Offerors have no rights under the laws of the PRC and the Articles of Association of the Company to compulsorily acquire the H Shares that are not tendered for acceptance pursuant to the Offer. Accordingly, the H Shareholders are reminded that if they do not accept the Offer and the Offer subsequently becomes unconditional in all respects, and the H Shares are delisted from the Stock Exchange, this will result in the H Shareholders holding securities that are not listed on the Stock Exchange and the liquidity of the H Shares may be severely reduced.

Unless the Offer is extended, the latest time and date for acceptance of the Offer will be 4:00 p.m. on 26 June 2017 ("Closing Date") and the latest date for posting of remittances for the amounts due under the Offer in respect of valid acceptances received at or before the latest time for acceptances of the Offer on the Closing Date will be 5 July 2017.


Topic: Press release summary Sectors: Daily Finance, Daily News, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report  
Nov 23, 2024 20:42 HKT/SGT
First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development  
Nov 22, 2024 23:22 HKT/SGT
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results  
Nov 22, 2024 19:56 HKT/SGT
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities  
Nov 22, 2024 11:00 HKT/SGT
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025  
Friday, November 22, 2024 10:00:00 AM
Jacobson Pharma Announces FY2025 Interim Results  
Nov 22, 2024 10:00 HKT/SGT
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth  
Thursday, November 21, 2024 9:59:00 PM
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry  
Nov 21, 2024 21:29 HKT/SGT
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer  
Nov 21, 2024 21:20 HKT/SGT
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness  
Nov 21, 2024 20:19 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575